Group Leader: COMPO (COMPutational pharmacology and clinical Oncology) @ Inria and Inserm

Marseille, France

Twitter: @SBenzekry
Website: https://team.inria.fr/compo/

Keywords (click a keyword to view other similar labs):
mechanistic learning • metastasis • pharmacometrics • biostatistics • clinical oncology • data science • quantitative personalized oncology • immunotherapy • predictive modeling • data science.

Description: The ambition of the COMPO Inria-Inserm joint project-team is to develop novel mathematical models integrating data available in clinical oncology (from clinical trials and routine care), in order to provide decision-making tools to oncologists. The main goals are : 1) to develop personalized medicine and 2) to optimize the design of scheduling regimen for combinatorial clinical trials. To achieve these, the team uniquely gathers mathematicians, pharmacologists and medical oncologists. It is integrated in the Center of Cancer Research of Marseille (Inserm U1068, CNRS UMR7258, Aix-Marseille Université UM105, Institut Paoli-Calmettes) and located in the La Timone Health Science campus of the University Hospitals of Marseille (AP-HM), close to the INCa-labeled center for early phase clinical trials (CLIP2). This joint project-team, built on strong expertise in mathematical modeling, pharmacometrics and experimental and clinical oncology, is committed to develop novel methodologies combining mechanistic and statistical modeling to be ultimately applied at bedside.